Rk1-loaded liposomes modified with ginsenoside structure achieved 97.24% encapsulation efficiency and enhanced tumor targeting through glucose transporter 1 (GLUT1) protein binding [117]. This evidence concerns the gene SLC2A1 and neoplasm.